The Reporter (Lansdale, PA)

Fauci says J&J shots could resume this week

- By Hope Yen

WASHINGTON >> The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictio­ns or broader warnings after reports of some very rare blood clot cases, the government’s top infectious diseases expert said Sunday. Dr. Anthony Fauci, in a series of news show interviews, said he expects a decision when advisers to the Centers for Disease Control and Prevention meet Friday to discuss the pause in J&J’s single-dose vaccine.

“I would be very surprised if we don’t have a resumption in some form by Friday,” he said. “I don’t really anticipate that they’re going to want it stretch it out a bit longer.”

Fauci, who is President Joe Biden’s chief medical adviser, said he believed that federal regulators could bring the shots back with restrictio­ns based on age or gender or with a blanket warning, so that it is administer­ed in a way “a little bit different than we were before the pause.”

The J&J vaccine has been in limbo after the CDC and the Food and Drug Administra­tion said last week that they needed more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the risk is.

The reports are rare — six cases out of more than 7 million U.S. inoculatio­ns with J&J vaccine. The clots were found in six women between the ages of 18 and 48. One person died.

The acting FDA commission­er had said she expected the pause to last only a matter of days. Still, the decision last Tuesday triggered swift action in Europe and elsewhere.

Fauci said he doubted very seriously that the U.S. would permanentl­y halt use of the J&J vaccine.

“I don’t think that’s going to happen,” he said. “The pause was to take a look, make sure we know all the informatio­n we can have within that timeframe, and also warn some of the physicians out there who might see people, particular­ly women, who have this particular adverse event, that they treat them properly.

“I think it’ll likely say, ‘OK, we’re going to use it. But be careful under these certain circumstan­ces.’”

More than 6.8 million doses of the J&J vaccine have been given in the U.S., the vast majority with no or mild side effects. Authoritie­s stressed they have found no sign of clot problems with the most widely used COVID-19 vaccines in the U.S. — from Moderna and Pfizer.

Fauci appeared on NBC’s “Meet the Press,” CNN’s “State of the Union,” ABC’s “This Week” and CBS’ “Face the Nation.”

 ??  ??
 ?? DAVID ZALUBOWSKI — THE ASSOCIATED PRESS FILE ?? Boxes stand next vials of Johnson & Johnson COVID-19vaccin. U.S. health officials are weighing next steps as they investigat­e unusual blood clots in a small number of people given the vaccine.
DAVID ZALUBOWSKI — THE ASSOCIATED PRESS FILE Boxes stand next vials of Johnson & Johnson COVID-19vaccin. U.S. health officials are weighing next steps as they investigat­e unusual blood clots in a small number of people given the vaccine.
 ??  ?? Fauci
Fauci

Newspapers in English

Newspapers from United States